Suppr超能文献

基于PINK1-Parkin通路探讨鸡鸣散改善线粒体自噬治疗心肌梗死的机制

[Mechanism of Jiming Powder in improving mitophagy for treatment of myocardial infarction based on PINK1-Parkin pathway].

作者信息

Fan Xin-Yi, Wei Xiao-Qi, Chai Wang-Jing, Gao Kuo, Li Fang-He, Yu Xue, Guo Shu-Zhen

机构信息

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine Beijing 100029, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2025 Jun;50(12):3346-3355. doi: 10.19540/j.cnki.cjcmm.20250303.401.

Abstract

In the present study, a mouse model of coronary artery ligation was employed to evaluate the effects of Jiming Powder on mitophagy in the mouse model of myocardial infarction and elucidate its underlying mechanisms. A mouse model of myocardial infarction post heart failure was constructed by ligating the left anterior descending branch of the coronary artery. The therapeutic efficacy of Jiming Powder was assessed from multiple perspectives, including ultrasonographic imaging, hematoxylin-eosin(HE) staining, Masson staining, and serum cardiac enzyme profiling. Dihydroethidium(DHE) staining was employed to evaluate the oxidative stress levels in the hearts of mice from each group. Mitophagy levels were assessed by scanning electron microscopy and immunofluorescence co-localization. Western blot was employed to determine the levels of key proteins involved in mitophagy, including Bcl-2-interacting protein beclin 1(BECN1), sequestosome 1(SQSTM1), microtubule-associated protein 1 light chain 3 beta(LC3B), PTEN-induced putative kinase 1(PINK1), phospho-Parkinson disease protein(p-Parkin), and Parkinson disease protein(Parkin). The results demonstrated that compared with the model group, high and low doses of Jiming Powder significantly reduced the left ventricular internal diameter in systole(LVIDs) and left ventricular internal diameter in diastole(LVIDd) and markedly improved the left ventricular ejection fraction(LVEF) and left ventricular fractional shortening(LVFS), effectively improving the cardiac function in post-myocardial infarction mice. Jiming Powder effectively reduced the levels of myocardial injury markers such as creatine kinase(CK), creatine kinase isoenzyme(CK-MB), and lactate dehydrogenase(LDH), thereby protecting ischemic myocardium. HE staining revealed that Jiming Powder attenuated inflammatory cell infiltration after myocardial infarction. Masson staining indicated that Jiming Powder effectively inhibited ventricular remodeling. Western blot results showed that Jiming Powder activated the PINK1-Parkin pathway, up-regulated the protein level of BECN1, down-regulated the protein level of SQSTM1, and increased the LC3Ⅱ/LC3Ⅰ ratio to promote mitophagy. In conclusion, Jiming Powder exerts therapeutic effects on myocardial infarction by inhibiting ventricular remodeling. The findings pave the way for subsequent pharmacological studies on the active components of Jiming Powder.

摘要

在本研究中,采用冠状动脉结扎小鼠模型来评估鸡鸣散对心肌梗死小鼠模型线粒体自噬的影响,并阐明其潜在机制。通过结扎冠状动脉左前降支构建心力衰竭后心肌梗死小鼠模型。从多个角度评估鸡鸣散的治疗效果,包括超声成像、苏木精-伊红(HE)染色、Masson染色和血清心肌酶谱分析。采用二氢乙锭(DHE)染色评估各组小鼠心脏的氧化应激水平。通过扫描电子显微镜和免疫荧光共定位评估线粒体自噬水平。采用蛋白质印迹法测定参与线粒体自噬的关键蛋白水平,包括Bcl-2相互作用蛋白beclin 1(BECN1)、聚集体蛋白1(SQSTM1)、微管相关蛋白1轻链3β(LC3B)、PTEN诱导的假定激酶1(PINK1)、磷酸化帕金森病蛋白(p-Parkin)和帕金森病蛋白(Parkin)。结果表明,与模型组相比,高剂量和低剂量鸡鸣散均显著降低收缩末期左心室内径(LVIDs)和舒张末期左心室内径(LVIDd),并显著提高左心室射血分数(LVEF)和左心室短轴缩短率(LVFS),有效改善心肌梗死后小鼠的心功能。鸡鸣散有效降低了心肌损伤标志物如肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)和乳酸脱氢酶(LDH)的水平,从而保护缺血心肌。HE染色显示,鸡鸣散减轻了心肌梗死后的炎症细胞浸润。Masson染色表明,鸡鸣散有效抑制了心室重构。蛋白质印迹结果显示,鸡鸣散激活了PINK1-Parkin通路,上调了BECN1蛋白水平,下调了SQSTM1蛋白水平,并增加了LC3Ⅱ/LC3Ⅰ比值以促进线粒体自噬。总之,鸡鸣散通过抑制心室重构对心肌梗死发挥治疗作用。这些发现为后续对鸡鸣散活性成分的药理学研究铺平了道路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验